To a Sustainable Quality Policy

NCT04200209 | Enrolling By Invitation

• 1 other identifier: SQP4ST
• Study Type: interventional
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators need stronger feedback loops and a quality monitoring and management system to improve the quality of care in sustainable way. The Chair Sint-Trudo "To a sustainable quality policy" was established to scientifically develop prerequisites for a sustainable quality of care. In this study protocol, a monocentric mixed-method quasi-experimental study will be used to assess the impact of a rapid-cycle quality indicator feedback mechanism on both patients and professionals.

Conditions

Quality Improvement; Public Health; Management Systems

Outcome Measures

Primary Outcomes (6)

• Hospital mortality

  In-hospital mortality rate

  During admission

• Patient experiences

  Experiences of patients will be measures by a validated questionnaire (Flemisch Patient Experience Questionnaire). Q: Will you recommend our hospital? (scale min 0 until 10 with 0: not and 10: for sure). For follow questions the scores are 'disagree', 'somewhat agree', 'largely agree', 'totally agree. The higher the score the better the outcome Q: This information was provided by my GP or by healthcare providers in the hospital. Q: I understand the information I received about the cost of my stay. Q: I received sufficient information about the causes of my condition or about the possible treatment methods for my condition or about the consequences of my disease. Q: Nurses or doctors explained things in a way I could understand or treated me with courtesy and respect. Q: My privacy was respected during conversations with caregivers or during examinations, treatment and care. Q: Before any treatment my identity was checked. Q: Hospital staff always introduced themselves

  During admission

• In-hospital length of stay

  Length of stay of each patient in the hospital

  During admission

• Adverse events and adverse outcomes

  Each adverse event and following adverse outcomes will be measured: urinary tract infections, pressure ulcers, hospital-acquired pneumonia, shock/cardiac arrest, upper-gastrointestinal bleeding, hospital-acquired sepsis, deep venous thrombosis, central nervous system complications, surgical wound infection, pulmonary failure, metabolic derangement, methicillin-resistant Staphylococcus aureus, vancomycin resistant Enterococcus, central line associated bloodstream infections, carbapenemase producing Enterobacteriaceae

  During admission

• Failure to rescue rate

  The failure to rescue rate for each patient admitted in the hospital will be evaluated

  During admission

• Readmission rate

  Readmission within 30 days of each patient admitted in the hospital

  30 days after discharge

Study Arms (1)

Hospital

EXPERIMENTAL

Twelve wards of the hospital will be evaluated at the same time.

Other: Implementation of a quality indicator feedback mechanism

Interventions

Implementation of a quality indicator feedback mechanism OTHER

1. Audit and feedback: A summary of clinical performance and hospital safety culture over a specified period of time. 2. Benchmarking Achievable: benchmarks are calculated from the performance of all members of a peer group and represents a realistic standard of excellence attained by the top performers in that group (i.e. comparing to the top 10% of peers). 3. Educational outreach: A trained independent person or investigator will meet with health professionals or managers in their practice setting to provide information (e.g. feedback of quality indicators). 4. Action planning: The purpose of action planning is to support quality improvement efforts by identifying opportunities for improvement, strategies and steps to accomplish the work.

Hospital

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients admitted in the hospital for more than one night

You may not qualify if:

• Patients admitted in the hospital for less than one night

Sponsors & Collaborators

• KU Leuven: lead
• Sint-Trudo Hospital: collaborator

Study Sites (1)

Sint-Trudo Ziekenhuis

Sint-Truiden, Belgium

Location

Study Officials

• Kris Vanhaecht, MSc

  Professor

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: December 11, 2019
• First Posted: December 16, 2019
• Study Start: August 15, 2020
• Primary Completion: January 1, 2025
• Study Completion (Estimated): June 1, 2026
• Last Updated: February 7, 2024

Record last verified: 2024-02

Locations

BE (1)